Investing

The 12 largest MSOs are ranked here as to their stock performances since the beginning of March and YTD, their likelihood of Financial Distress within the next 2 years, their average 12-month Price Targets, the extent of Short Interest and Insider Ownership.

In summary, the 5 cannabis/cannabis-related company stock category performances ranged from: -4.4% to -14.3% YTD.

On average, the 12-month forecasts represent an increase of 65% but so far their YTD percentages are universally down.

The 7 largest psychedelic drug stocks are ranked as to their stock performances since the beginning of March and year-to-date, their likelihood of financial distress, analyst price forecasts and the extent of short interest and insider ownership.

This article tracks the performance of the largest Canadian cannabis LPs, American cannabis MSOs, psychedelic drug stocks and plant-based food stocks in four separate munKNEE indexes on a weekly basis and this is an update on how the various categories in the Portfolio, and their constituents, have performed month-to-date (MTD) and year-to-date (YTD).

Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 - DOWN 73% vs. 2021 - but perhaps some of them will bounce back with major - dare I say "multi-bagger" - returns in 2023.

Incannex has the world’s largest portfolio of patented medicinal cannabis drug formulations with 28 clinical and pre-clinical research and development projects in its pipeline which have a combined global addressable market of approximately US$400B per annum.

The 7 largest psychedelic drug stocks are ranked below as to their likelihood of Financial Distress within the next 2 years, their average year-end price targets as well as their stock performances last week and since the end of January.

To help you with your investment decisions, this article presents the stock performance of each of the 5 largest Canadian cannabis licensed producers (LPs) in the munKNEE Canadian Cannabis LPs Index this week and in the last 6 weeks in descending order,

This article presents the stock performance of each of the 12 largest American cannabis multi-state operators (MSOs) in the munKNEE American Cannabis MSOs Index this week and in the last 6 weeks.